首页> 外国专利> Pharmacological components include IOTA and/or Kappa Carragenina and a neurosuppressor selected from Zanamivir, Oseltamivir, Peramivir and Laninavir; used alone or in combination with nephrovirus, coronavirus or Paramixivivivivir in the treatment of influenza virus infections.

Pharmacological components include IOTA and/or Kappa Carragenina and a neurosuppressor selected from Zanamivir, Oseltamivir, Peramivir and Laninavir; used alone or in combination with nephrovirus, coronavirus or Paramixivivivivir in the treatment of influenza virus infections.

机译:药理成分包括IOTA和/或Kappa Carragenina以及选自Zanamivir,Oseltamivir,Peramivir和Laninavir的神经抑制剂;单独使用或与肾病毒,冠状病毒或副交配体结合用于治疗流感病毒感染。

摘要

T. P composici amp; oacute; n Pharma amp; eacute; Utica, including iota and / or kappa carroagina and amp; nbsp; a neurosensitive inhibitor selected between zanamivir, oseltamivir, peramivir and laninavivir; for the treatment of an infectious and mixed epidemic virus; oacute; N and rinovirus, coronavirus and paramilt virus; /P GT;
机译:T. P GT;组合放大器ac n医药放大器;敏锐Utica,包括iota和/或kappa carroagina和amp; nbsp;在扎那米韦,奥司他韦,帕拉米韦和拉尼那韦之间选择的神经敏感性抑制剂;用于治疗传染性和混合性流行病毒; ac N和鼻病毒,冠状病毒和准乳病毒; / P GT;

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号